what glp-1 are approved for weight loss Semaglutide Injections in Sarasota FL GLP-1 Safety Check - National

, Jorgensen, N

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. New England Journal of Medicine , vol

It's to drive sustained weight loss outcomes."

"Efficacy and safety of retatrutide, a novel GLP-1, GIP, and glucagon receptor agonist for obesity treatment: a systematic review and meta-analysis of randomized controlled trials." Frontiers in Endocrinology

GLP-1 receptor agonists provide important cardiometabolic benefits, particularly for weight management, glycemic control, renal protection, and reduction of atherosclerotic cardiovascular risk, although their direct effects in established heart failure remain less certain